Edition:
United States

Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

60.30TWD
29 Mar 2017
Change (% chg)

NT$-0.50 (-0.82%)
Prev Close
NT$60.80
Open
NT$60.20
Day's High
NT$61.00
Day's Low
NT$60.00
Volume
306,000
Avg. Vol
728,562
52-wk High
NT$93.40
52-wk Low
NT$50.60

3176.TWO

Chart for 3176.TWO

About

MEDIGEN BIOTECHNOLOGY CORP. is engaged in the research and development of new drugs and the testing of nucleic acids. It involves in the licensing of technologies, the provision of technical services and the testing of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents,... (more)
No analyst recommendations are available for 3176.TWO.

Overall

Beta: 0.95
Market Cap(Mil.): NT$8,432.08
Shares Outstanding(Mil.): 138.69
Dividend: --
Yield (%): --

Financials

  3176.TWO Industry Sector
P/E (TTM): -- 49.14 30.32
EPS (TTM): -4.30 -- --
ROI: -27.92 -2.23 13.10
ROE: -24.29 5.00 14.24

More From Around the Web

Earnings vs. Estimates